Evercore ISI Group Maintains Outperform on Guardant Health, Raises Price Target to $200
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Vijay Kumar maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $160 to $200.
Evercore ISI Group analyst Vijay Kumar maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $160 to $200.